Associate Director, US Real-World Evidence and Health Outcomes – Oncology Pipeline

Responsibilities:
- Co-develop and maintain US RWE & HO plans for 1–2 priority Oncology pipeline assets/indications aligned to US medical, payer, and access needs; translate strategy into workplans, timelines, and resourcing proposals; provide backup portfolio support as needed.
- Own day-to-day leadership for assigned real-world evidence and health outcomes studies (e.g., RWE studies, cost-effectiveness/budget impact analyses, burden of illness, treatment patterns, patient-focused outcomes), including design and execution with internal functions and external vendors.
- Support cross-functional evidence strategy forums and asset-specific meetings by developing agendas/materials, surfacing options, documenting decisions, and tracking actions to closure.
- Draft/review project specifications, protocols, statistical analysis plans, study reports, abstracts, posters, and manuscripts; ensure adherence to SOPs and high scientific/operational quality.
- Provide input on trial design to ensure US-relevant patient enrollment and collection of endpoints/outcomes needed by US stakeholders (e.g., HRQoL, patient-reported outcomes, resource utilization).
- Provide RWE & HO input for internal decision-making during development and commercialization planning (e.g., trial design considerations, data gap assessments, value messages, evidence prioritization/sequencing).
- Contribute ~20% effort to US RWE & HO strategy and execution for a marketed Oncology product in endometrial and rectal cancer, including data generation planning and delivery of analyses/publications for lifecycle evidence and value communication.
- Generate external insights by aligning with Field Based Payer Medical Teams and other field stakeholders; incorporate insights into evidence plans and value communication.
- Manage vendors/contractors for assigned studies (scope, timelines, budget tracking, change control); proactively escalate risks/issues.
- Complete required training, adhere to SOPs, and contribute to continuous improvement of planning/execution/dissemination processes.

Required qualifications/skills:
- Master’s or PhD in health economics/outcomes research, epidemiology, public health, biostatistics, or related.
- 1–3 years’ experience in pharmaceutical industry and/or managed care, hospital, academic, or healthcare consulting with exposure to HEOR/RWE strategy and application.
- Knowledge of US payer/reimbursement/access environment and how payer evidence needs inform evidence planning/deliverables.
- Expertise in RWE and economic evaluation study designs/methods (including bias/confounding mitigation), with experience authoring/reviewing statistical analysis plans and study reports and ensuring publication/disclosure readiness.
- Strong communication/presentation skills and ability to produce decision-oriented materials for senior audiences.
- Proven ability to prioritize and manage multiple projects in a matrix environment.

Preferred qualifications:
- Demonstrated success executing health outcomes research and delivering high-quality data outputs.
- Oncology experience (US/global).
- Advanced experience (Masters+: 4–6 years or PhD: 2–4+ years) plus collaboration with field-facing teams and/or Market Access partners.
- Experience managing real-world data sources/vendors (claims, EHR, registries) and translating findings into actionable insights/value messages.
- Ability to influence without authority; align stakeholders, document decisions, and drive actions to closure.
- Strategic execution experience delivering outputs across 1–2 concurrent asset workstreams.
- Project/vendor management experience (scope, success criteria, budgets/timelines, risk mitigation via change control).
- Experience contributing to congress strategy and publication planning (abstracts/posters/manuscripts).

How to apply:
- Apply and describe how your experience in economic modelling and real-world evidence will support access and better patient outcomes.